Search results
Feb 11, 2021 · The company has previously divested Fortum and Zinacef in the US and Germany and Fortum and Zinnat in Australia. The transaction includes all other markets except India, Pakistan, Egypt, Japan (relating to local Fortum brands) and China (excluding Taiwan, Hong Kong and Macau).
Oct 11, 2021 · Basel, October 11, 2021 – Sandoz, a Novartis division, has successfully completed the acquisition of GSK’s cephalosporin antibiotics business. Through this transaction, Sandoz has acquired rights to three established brands (Zinnat, Zinacef and Fortum)) in more than 100 markets, further reinforcing its leading global position in antibiotics.
Feb 11, 2021 · Basel, February 11, 2021 – Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. The agreement includes the global rights to three established brands (Zinnat ®, Zinacef ® and Fortum ®)) in more than 100 markets.
Oct 11, 2021 · Basel, October 11, 2021 – Sandoz, a Novartis division, has successfully completed the acquisition of GSK’s cephalosporin antibiotics business. Through this transaction, Sandoz has acquired...
Oct 11, 2021 · Through the acquisition of GSK's cephalosporin antibiotics business, Sandoz obtained the rights to GSK’s Zinnat, Zinacef and Fortum brands. October 11, 2021. Sandoz buys GSK’s cephalosporin antibiotics business to strengthen its antibiotics capabilities. Credit: Steve Buissinne / Pixabay.
Feb 11, 2021 · Swiss drugmaker Novartis' generics division is buying a GlaxoSmithKline antibiotics business that includes the brands Zinnat, Zinacef and Fortum for up to $500 million, the drugmakers said on ...
People also ask
Does Sandoz own GSK?
Is Sandoz acquiring GSK in cephalosporins?
What is GSK doing about cephalosporins?
Does GSK sell cephalosporin antibiotics?
Feb 11, 2021 · Globe Newswire. Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. Novartis International AG. 11 February...
